Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

1110 Rislenemdaz
e4aa9b71dbfa7682b114704fb1bd35bf4f2196fa1c78cd194ec7caebf0ceb5eb

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Rislenemdaz (developmental code names CERC-301, MK-0657) is an orally-active, selective NMDA receptor subunit 2B (NR2B) antagonist which is under development by Cerecor in the United States as an adjunctive therapy for treatment-resistant depression (TRD). In November 2013, phase II clinical trials were initiated, and in the same month, rislenemdaz received Fast Track Designation from the Food and Drug Administration for TRD.

From Wikipedia, the free encyclopedia. License: CC BY-SA.